News
Qualcomm's deals with Novartis and Walgreens, announced this week at CES, give the pharma giant and pharmacy chain access to the 2net platform, which collects data from mobile devices.
The closure of Ideomed, a Michigan-based developer of mHealth apps, may be a signal that the market is saturated.